ESC 365 - Cardioprotective effect of LCZ696 versus valsartan on left ventricular remodeling in experimental model of chronic heart failure

HFA Premium Access

Cardioprotective effect of LCZ696 versus valsartan on left ventricular remodeling in experimental model of chronic heart failure

Session: Poster Session 1 - Basic Science - Therapeutic approach

Topic: Animal models and experimentation

Speaker: Doctor L. Hoskova (Prague, CZ)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Doctor Lenka Hoskova

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

0 follower

9 more presentations in this session

Cardiac gene therapy with phosphodiesterases PDE2A and PDE4B in a mouse model of heart failure

Speaker: Mr J. Margaria (Turin, IT)

Acute and subacute functional effects of relaxin-2 on human mammary artery

Speaker: Doctor F. Vasques-Novoa (Porto, PT)

Microencapsulated insulin-like growth factor 1 improves cardiac function after experimental myocardial infarction in comparison to low-dose mesenchymal stem cells

Speaker: Doctor C. Baez Diaz (Madrid Caceres, ES)

Pharmacological activation of sphingosine 1-phosphate receptor 1 (S1pr1) enhances arteriole formation and improves cardiac function after myocardial infarction (MI)

Speaker: Professor L. Zhang (Shanghai, CN)

Raf kinase inhibitor protein regulates fibrosis depending on myocardial oxidative stress

Speaker: Doctor A. Kazakov (Homburg, DE)

Access the full session

Poster Session 1 - Basic Science - Therapeutic approach

Speakers: Doctor L. Hoskova, Mr J. Margaria, Doctor F. Vasques-Novoa, Doctor C. Baez Diaz, Professor L. Zhang...

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources